FDA Seeks Speedier Seizure, Injunction Decisions Via Protocol Changes
This article was originally published in The Rose Sheet
Executive Summary
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.